Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.
A recent study suggests that a common chemical byproduct created by the breakdown of automobile tires might interfere with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results